Cargando…

Clinical significance of non-thyroidal illness syndrome on disease activity and dyslipidemia in patients with SLE

OBJECTIVES: Nonthyroidal illness syndrome (NTIS), also known as low triiodothyronine (T3) syndrome, frequently affects patients with systemic lupus erythematosus (SLE) and may affect lipid metabolism. Dyslipidemia is highly prevalent and associated with the long-term prognosis of SLE. The aim of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xin, Liu, Lirong, Ma, Xiaolei, Hu, Wei, Xu, Xue, Huang, Saisai, Hua, Bingzhu, Wang, Hong, Chen, Zhiyong, Sun, Lingyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162454/ https://www.ncbi.nlm.nih.gov/pubmed/32298352 http://dx.doi.org/10.1371/journal.pone.0231622

Ejemplares similares

Dyslipidemia is associated with inflammation and organ involvement in systemic lupus erythematosus
por: Huang, Saisai, et al.
Publicado: (2023)

Liver damage in primary biliary cirrhosis and accompanied by primary Sjögren's syndrome: a retrospective pilot study
por: Zhu, Yun, et al.
Publicado: (2016)

Associations of metabolic syndrome in SLE
por: Apostolopoulos, Diane, et al.
Publicado: (2020)

An update on non-thyroidal illness syndrome
por: Fliers, E., et al.
Publicado: (2020)

The effect of Thyroid Autoimmunity on Dyslipidemia in patients with Euthyroid Hashimoto Thyroiditis
por: Cengiz, Hasret, et al.
Publicado: (2021)

Hashimoto Thyroiditis and Dyslipidemia in Childhood: A Review
por: Vukovic, Rade, et al.
Publicado: (2019)

Prognostic significance of low TSH concentration in patients with COVID-19 presenting with non-thyroidal illness syndrome
por: Gong, Jing, et al.
Publicado: (2021)

Adiposity significantly modifies genetic risk for dyslipidemia
por: Cole, Christopher B., et al.
Publicado: (2014)

Study of the Significance of Thromboelastography Changes in Patients with Dyslipidemia
por: Lin, Qing, et al.
Publicado: (2022)

Tonic-Clonic Seizure in Patient With SLE: Posterior Reversible Encephalopathy Syndrome, or a Neuropsychiatric Manifestation of SLE?
por: Ozturk, Yasin, et al.
Publicado: (2023)

Dyslipidemia and serum mineral profiles in patients with thyroid disorders
por: Abdel-Gayoum, Abdelgayoum A.
Publicado: (2014)

Thyroid dysfunction and dyslipidemia in chronic kidney disease patients
por: Khatiwada, Saroj, et al.
Publicado: (2015)

Association of thyroid peroxidase antibody and dyslipidemia in subclinical hypothyroidism
por: Srivastava, Vikas Kumar, et al.
Publicado: (2017)

SLE and APS
por: Avcin, Tadej
Publicado: (2014)

Epigenetics in SLE
por: Hedrich, Christian Michael
Publicado: (2017)

HBsAb and HBcAb Have No Significant Effect on the Progression of SLE and RA
por: WANG, Fen, et al.
Publicado: (2017)

Phenotypical changes and clinical significance of CD4(+)/CD8(+) T cells in SLE
por: Yuan, Shiwen, et al.
Publicado: (2022)

Gut microbiota is a potential goalkeeper of dyslipidemia
por: Lei, Lirong, et al.
Publicado: (2022)

Characterization of the Phosphoproteome in SLE Patients
por: Zhang, Xinzhou, et al.
Publicado: (2012)

Thyroid Hormones Interaction With Immune Response, Inflammation and Non-thyroidal Illness Syndrome
por: De Luca, Roberto, et al.
Publicado: (2021)

Atherosclerosis, Dyslipidemia, and Inflammation: The Significant Role of Polyunsaturated Fatty Acids
por: Dessì, Mariarita, et al.
Publicado: (2013)

Lack of significant association between dyslipidemia and COVID-19 mortality
por: Yang, Haiyan, et al.
Publicado: (2021)

Non-thyroidal illness syndrome and its relationship with mortality risk in critically ill children
por: Carreras, Laura, et al.
Publicado: (2023)

Prevalence of Dyslipidemia and Hypertension in Indian Type 2 Diabetic Patients with Metabolic Syndrome and its Clinical Significance
por: Yadav, Dhananjay, et al.
Publicado: (2014)

New Insights toward the Acute Non-Thyroidal Illness Syndrome
por: Wajner, Simone Magagnin, et al.
Publicado: (2012)

SLE - Rituximab in lupus
por: Eisenberg, Robert
Publicado: (2003)

1. SLE and Pregnancy
por: Khan, Afsha, et al.
Publicado: (2017)

SLE: reconciling heterogeneity
por: Lockshin, Michael D, et al.
Publicado: (2019)

Cutaneous vasculitis in SLE
por: Kallas, Romy, et al.
Publicado: (2020)

Genotype-guided new approach for dose optimisation of hydroxychloroquine administration in Chinese patients with SLE
por: Xie, Han, et al.
Publicado: (2023)

Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations
por: Wang, Chuan, et al.
Publicado: (2013)

Editorial: Mechanisms by Which SLE-Associated Genetic Variants Contribute to SLE Pathogenesis
por: Crispín, José C., et al.
Publicado: (2019)

Dyslipidemia in women with polycystic ovary syndrome
por: Kim, Jin Ju, et al.
Publicado: (2013)

How is the Metabolic Syndrome Related to the Dyslipidemia?
por: Blaton, Victor
Publicado: (2007)

Hypogonadism Makes Dyslipidemia in Klinefelter's Syndrome
por: Lee, Hyo Serk, et al.
Publicado: (2017)

Predicting dyslipidemia after liver transplantation: A significant role of recipient metabolic inflammation profile
por: Huang, Hai-Tao, et al.
Publicado: (2020)

Risk factors of significant relapse and appropriate maintenance therapy strategy in SLE-associated immune thrombocytopenia
por: Li, He-Jun, et al.
Publicado: (2023)

What to Expect When Expecting With Systemic Lupus Erythematosus (SLE): A Population‐Based Study of Maternal and Fetal Outcomes in SLE and Pre‐SLE
por: Arkema, Elizabeth V., et al.
Publicado: (2016)

Impact of thyroid cancer on the cancer risk in patients with non-alcoholic fatty liver disease or dyslipidemia
por: Ho, Joon, et al.
Publicado: (2023)

Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy
por: Tonsawan, Pantipa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oqfs4s5hqu1vfpb29ipg58qabq